THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
S P H Alexander(University of Nottingham), Scott A. Waldman(Thomas Jefferson University), David J. MacEwan(University of Liverpool), Annie Beuve(Rutgers, The State University of New Jersey), Doriano Fabbro(Novartis (Switzerland)), Alistair Mathie(University of Westminster), Andreas Friebe(University of Würzburg), Elena Faccenda(University of Edinburgh), John Garthwaite(University College London), Christopher Southan(University of Edinburgh), Lincoln R. Potter(University of Minnesota), Clare Bryant(University of Cambridge), Harald Schmidt(Maastricht University Medical Centre), Eamonn Kelly(University of Bristol), Emma L. Veale(Medway School of Pharmacy), Simon D Harding(Neurosciences Institute), Adrian J. Hobbs(Queen Mary University of London), John A. Peters(Centre National de la Recherche Scientifique), Gavin E. Jarvis(University of Sunderland), Richard W. Farndale(University of Cambridge), Peter Brouckaert(Vlaams Instituut voor Biotechnologie), Jane F Armstrong(Neurosciences Institute), Jamie A. Davies(University of Edinburgh), Tom P. Monie(University of Cambridge), Michaela Kühn(Universitätsklinikum Würzburg), John C. Burnett(Mayo Clinic), Adam J Pawson(University of Edinburgh)
Cited by 171
Related Papers
Guide to Receptors and Channels (GRAC), 5th edition
|British Journal of Pharmacology|2011|1.9k
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity
|Molecular Cancer Therapeutics|2008|1.1k